Most of the experiments proposed in this grant will require production of lentiviral and AAV vectors. The goal of the Vector Core is therefore to produce research grade vectors to support the proposed experiments. This function will ensure the availability of vector preparations of high quality for experiments using AAV and lentiviral vectors in vitro and in vivo.

Agency
National Institute of Health (NIH)
Type
Research Program Projects (P01)
Project #
5P01HL064190-14
Application #
8691971
Study Section
Heart, Lung, and Blood Program Project Review Committee (HLBP)
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Sauna, Zuben E; Lozier, Jay N; Kasper, Carol K et al. (2015) The intron-22-inverted F8 locus permits factor VIII synthesis: explanation for low inhibitor risk and a role for pharmacogenomics. Blood 125:223-8
Sullivan, Spencer K; Mills, Jason A; Koukouritaki, Sevasti B et al. (2014) High-level transgene expression in induced pluripotent stem cell-derived megakaryocytes: correction of Glanzmann thrombasthenia. Blood 123:753-7
Sherman, Alexandra; Schlachterman, Alexander; Cooper, Mario et al. (2014) Portal vein delivery of viral vectors for gene therapy for hemophilia. Methods Mol Biol 1114:413-26
Yazicioglu, Mustafa N; Monaldini, Luca; Chu, Kirk et al. (2013) Cellular localization and characterization of cytosolic binding partners for Gla domain-containing proteins PRRG4 and PRRG2. J Biol Chem 288:25908-14
Callejas, David; Mann, Christopher J; Ayuso, Eduard et al. (2013) Treatment of diabetes and long-term survival after insulin and glucokinase gene therapy. Diabetes 62:1718-29
Siner, Joshua I; Iacobelli, Nicholas P; Sabatino, Denise E et al. (2013) Minimal modification in the factor VIII B-domain sequence ameliorates the murine hemophilia A phenotype. Blood 121:4396-403
Mingozzi, Federico; High, Katherine A (2013) Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood 122:23-36
Anguela, Xavier M; Sharma, Rajiv; Doyon, Yannick et al. (2013) Robust ZFN-mediated genome editing in adult hemophilic mice. Blood 122:3283-7
Buchlis, George; Podsakoff, Gregory M; Radu, Antonetta et al. (2012) Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer. Blood 119:3038-41
Mingozzi, Federico; High, Katherine A (2011) Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet 12:341-55

Showing the most recent 10 out of 39 publications